Fund Holdings — Qiming U.S. Ventures Management, LLC

Total Portfolio Value
$51.15M
Total Bought
$556.9K
Total Sold
$850.5K
Net Transaction
-$293.6K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
JASPER THERAPEUTICS INC(JSPR)928,964928,964017,47419,86138.83%+2,387
KORRO BIO INC(KRRO)368,085368,085012,30114,01327.40%+1,712
KEZAR LIFE SCIENCES INC
COM NEW
082,871+82,87105571.09%+557
VENTYX BIOSCIENCES INC412,225412,22508999031.77%+4
HILLEVAX INC558,923372,615-186,3089847711.51%-212
KEZAR LIFE SCIENCES INC828,7110-828,7116380—-638
TOURMALINE BIO INC741,691741,691019,06915,04129.41%-4,027
Page 1 of 1
Qiming U.S. Ventures Management, LLC — 13F Holdings — Q4 2024 | TickerTrail